Washington: Pfizer Inc and partner BioNTech SE’s COVID-19 vaccine candidate produced no severe allergic reactions during clinical trials, a Pfizer executive said at a regulatory conference on Friday.
According to Dr William Gruber, Pfizer’s senior vice president of vaccine clinical research and development, a late-stage trial testing the potential vaccine excluded participants who had a prior history of severe allergic reactions to any vaccine or to the constituents of Pfizer/BioNTech vaccine.
“We’ve not had any anaphylactic episodes related to the vaccine,” Gruber was quoted as saying during a panel meeting of independent advisers to the US Centres for Disease Control and Prevention by news agency Reuters.
According to Pfizer executive Susan Mather, the trial included about 6,000 participants respectively in both the vaccine and placebo groups with a history of a range of allergic conditions like pollen allergy, food allergy, all the way up to anaphylaxis.
Lucknow: Three terrorists accused of lobbing a grenade at a police post in Punjab’s Gurdaspur…
Malkangiri: If things go as per plan, flight services between Odisha’s Malkangiri town and Visakhapatnam…
Bhubaneswar: Unidentified miscreants allegedly attacked a man and kidnapped his female friend in Maitri Vihar…
Balasore: A young man was allegedly beaten to death on the suspicion of having committed…
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
This website uses cookies.